Comparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019: a systematic review and network meta-analysis combining 66 trials

Shan-Shan WU; Qing-Xin ZHOU; Xue-Yang ZENG; Jing-Xue ZHANG; Zhi-Rong YANG; Qing-Qing YANG; Zi-Lu ZHANG; Ya-Hong CHEN; Feng SUN; Si-Yan ZHAN.
Chinese Medical Journal ; (24): 1920-1929, 2021.
Artículo en Inglés | WPRIM | ID: wpr-887628

Documentos relacionados

  1. Comparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019: a systematic review and network meta-analysis combining 66 trials.
  2. Host Recovery from Respiratory Viral Infection.
  3. A systematic review of outcomes in COVID-19 patients treated with western medicine in combination with traditional Chinese medicine versus western medicine alone.
  4. The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.
  5. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children.
  6. Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.
  7. The humoral response and antibodies against SARS-CoV-2 infection.
  8. Better, Faster, Cheaper: Recent Advances in Cryo-Electron Microscopy.
  9. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
  10. Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis.